cjc-1295 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-06-26. Where a claim depends on a specific study, the study is described rather than over-claimed.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
| Property | Value | Notes |
|---|---|---|
| Target receptor | GHRH receptor (GHRHR) | Expressed on pituitary somatotrophs |
| Primary action | Stimulates growth hormone release | Amplifies pulse size |
| Half-life, albumin-binding form | Several days as reported | Slow release from albumin complex |
| Half-life, unmodified analog | About 30 minutes in animal estimates | Cleared by proteases and filtration |
| Common analytical approach | LC-MS/MS for peptide, immunoassay for hormones | Methods answer different questions |
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
Laboratory handling centers on minimizing exposure to water, heat and oxygen before use. Working solutions are typically prepared in sterile water or a mild buffer, and any residual particulate matter is removed by filtration. When the powder dissolves slowly, a small proportion of acetonitrile or dilute acetic acid is sometimes added as a co-solvent. Containers are kept sealed and desiccated between uses. Records of lot number, reconstitution date and storage conditions support later comparison of results across experiments.
Identity and purity are established with reversed phase high performance liquid chromatography coupled to mass spectrometry. The chromatographic step separates the target peptide from truncated sequences and deletion products, while the mass measurement confirms the expected molecular weight to within a fraction of a dalton. Because the two common variants differ by the presence of the linker, mass alone can distinguish them in the unconjugated state. Amino acid analysis and peptide mapping are used when sequence level confirmation is required.
Marfan syndrome is caused by mutations in the FBN1 gene on chromosome 15, which encodes fibrillin 1, a glycoprotein component of the extracellular matrix. Fibrillin-1 is essential for the proper formation of the extracellular matrix, including the biogenesis and maintenance of elastic fibers. The extracellular matrix is critical for the structural integrity of connective tissue, but also serves as a reservoir for growth factors. Elastic fibers are found throughout the body, but are particularly abundant in the aorta, ligaments, and the ciliary zonules of the eye; consequently, these areas are among the worst affected. A transgenic mouse has been created carrying a single copy of a mutant fibrillin-1, a mutation similar to that found in the human gene known to cause MFS. This mouse strain recapitulates many of the features of the human disease and promises to provide insights into the pathogenesis of the disease. Reducing the level of normal fibrillin 1 causes a Marfan-related disease in mice. Transforming growth factor beta (TGF-β) plays an important role in MFS. Fibrillin-1 directly binds a latent form of TGF-β, keeping it sequestered and unable to exert its biological activity. The simplest model suggests reduced levels of fibrillin-1 allow TGF-β levels to rise due to inadequate sequestration. Although how elevated TGF-β levels are responsible for the specific pathology seen with the disease is not proven, an inflammatory reaction releasing proteases that slowly degrade the elastic fibers and other components of the extracellular matrix is known to occur.
Genetic defects in the creatine biosynthetic pathway enzymes lead to various severe neurological defects. Defects in the two synthesis enzymes cause L-arginine:glycine amidinotransferase deficiency and guanidinoacetate methyltransferase deficiency. Both biosynthetic defects are inherited in an autosomal recessive manner. Creatine transporter defect, characterized by insufficient transport of creatine to the brain, is caused by mutations in SLC6A8 and is inherited in an X-linked manner.
The Riksdag performs the normal functions of a legislature in a parliamentary democracy. It enacts laws, amends the constitution and appoints a government. In most parliamentary democracies, the head of state commissions a politician to form a government. Under the new Instrument of Government (one of the four fundamental laws of the Constitution) enacted in 1974, that task was removed from the monarch of Sweden and given to the speaker of the Riksdag. To make changes to the Constitution under the new Instrument of Government, amendments must be approved twice, in two successive electoral periods with a regular general election held in between. There are 15 parliamentary committees in the Riksdag.
While no correlation between race and the level of neuromelanin in the substantia nigra has been reported, the significantly lower incidence of Parkinson's in blacks than in whites has "prompt[ed] some to suggest that cutaneous melanin might somehow serve to protect the neuromelanin in substantia nigra from external toxins." In addition to melanin deficiency, the molecular weight of the melanin polymer may be decreased by various factors such as oxidative stress, exposure to light, perturbation in its association with melanosomal matrix proteins, changes in pH, or in local concentrations of metal ions. A decreased molecular weight or a decrease in the degree of polymerization of ocular melanin has been proposed to turn the normally anti-oxidant polymer into a pro-oxidant. In its pro-oxidant state, melanin has been suggested to be involved in the causation and progression of macular degeneration and melanoma. Rasagiline, an important monotherapy drug in Parkinson's disease, has melanin binding properties, and melanoma tumor reducing properties. Higher eumelanin levels also can be a disadvantage, however, beyond a higher disposition toward vitamin D deficiency. Dark skin is a complicating factor in the laser removal of port-wine stains. Effective in treating white skin, in general, lasers are less successful in removing port-wine stains in people of Asian or African descent. Higher concentrations of melanin in darker-skinned individuals simply diffuse and absorb the laser radiation, inhibiting light absorption by the targeted tissue.
Type II civilizations could use the same techniques as a Type I civilization, but applied to a large number of planets in a large number of star systems. A Dyson sphere or Dyson swarm and similar constructs are hypothetical megastructures originally described by Freeman Dyson as a system of orbiting solar power satellites designed to completely encircle a star and capture most or all of its energy output. Another means of generating usable energy would be to feed a stellar mass into a black hole, and collect the photons emitted by the accretion disk. A less exotic means would be to simply capture photons already escaping from the accretion disk, thereby reducing a black hole's angular momentum; this is known as the Penrose process. However, this may only be possible for a Type III civilization. Star lifting is a process by which an advanced civilization could remove a substantial portion of a star's matter in a controlled manner for other uses. Antimatter is likely to be produced as an industrial byproduct of a number of megascale engineering processes (such as the aforementioned star lifting), and could therefore be recycled. In multiple star systems with a sufficiently large number of stars: absorbing a small but significant fraction of the output of each individual star. Stellar engines can be used to move stars.
Sources: en.wikipedia.org
=== Musculoskeletal symptoms === Joint instability and soft tissue injuries: Dislocations, subluxations, or damage to muscles, ligaments, tendons, synovium, or cartilage as a result of excessive joint movement. Chronic pain: Recurrent joint pain that can develop into hyperalgesia, with a higher rate of small fiber neuropathy in some individuals. Disturbed proprioception: Reduced proprioception and muscle weakness, creating a cycle of increasing activity limitations
== Applications == There is almost no use for any isotope of einsteinium outside basic scientific research aiming at production of higher transuranium elements and superheavy elements. In 1955, mendelevium was synthesized by irradiating a target consisting of about 109 atoms of 253Es in the 60-inch cyclotron at Berkeley Laboratory. The resulting 253Es(α,n)256Md reaction yielded 17 atoms of the new element with the atomic number of 101. The rare isotope 254Es is favored for production of superheavy elements due to its large mass, relatively long half-life of 270 days, and availability in significant amounts of several micrograms. Hence 254Es was used as a target in the attempted synthesis of ununennium (element 119) in 1985 by bombarding it with calcium-48 ions at the superHILAC linear particle accelerator at Berkeley, California. No atoms were identified, setting an upper limit for the cross section of this reaction at 300 nanobarns.
=== „Gott ist schön“ (Dissertation 1998) === A parallel (including excursions into the scholarly realm) is discernable here with Kermani's narratively oriented 1999 dissertation „Gott ist schön“ (God is Beautiful). The dissertation, after all, investigates the (musical) aesthetics of the Koran and contains a subchapter entitled “Those Killed by the Koran“.
Absolute bioavailability compares the bioavailability of the active drug in systemic circulation following non-intravenous administration (i.e., after oral, buccal, ocular, nasal, rectal, transdermal, subcutaneous, or sublingual administration), with the bioavailability of the same drug following intravenous administration. It is the fraction of exposure to a drug (AUC) through non-intravenous administration compared with the corresponding intravenous administration of the same drug. The comparison must be dose normalized (e.g., account for different doses or varying weights of the subjects); consequently, the amount absorbed is corrected by dividing the corresponding dose administered. In pharmacology, in order to determine absolute bioavailability of a drug, a pharmacokinetic study must be done to obtain a plasma drug concentration vs time plot for the drug after both intravenous (iv) and extravascular (non-intravenous, i.e., oral) administration. The absolute bioavailability is the dose-corrected area under curve (AUC) non-intravenous divided by AUC intravenous. The formula for calculating the absolute bioavailability, F, of a drug administered orally (po) is given below (where D is dose administered).
Sources: en.wikipedia.org
Entertainment Weekly critic Owen Gleiberman wrote that DiCaprio did not look old enough to play the part, but praised him as "a fluid and instinctive actor, with the face of a mischievous angel". The Guardian's Alex von Tunzelmann was similarly impressed with the actor's performance but found his talent wasted in the film. DiCaprio won a Golden Raspberry Award for Worst Screen Couple for the dual roles in 1999. Following the release of Titanic, and The Man in the Iron Mask, DeCaprio chose to reduce his workload "to learn to hear [his] own voice in choosing the roles" that he wanted to pursue. He said in 2000: "I have no connection with me during that whole Titanic phenomenon and what my face became around the world [...] I'll never reach that state of popularity again, and I don't expect to [...] It's not something I'm going to try to achieve either." DiCaprio was next cast to star in an earlier version of American Psycho (2000) for a reported salary of $20 million; after disagreements with Oliver Stone on the film's direction, DiCaprio left the project, taking the lead role in The Beach instead. Adapted from Alex Garland's 1996 novel, the film saw him play a backpacking American tourist who ends up in a secret island commune in the Gulf of Thailand. Budgeted at $50 million, the film earned almost three times that at the box office, but was negatively reviewed by critics, and earned him a nomination for the Golden Raspberry Award for Worst Actor. Todd McCarthy of Variety thought DiCaprio gave a compelling performance but his character lacked defining qualities.
== Examples of GxPs == Good agricultural and collection practices, or GACP(s) Good agricultural practice, or GAP Good auditing practice, or GAP Good automated laboratory practice, or GALP Good automated manufacturing practice, or GAMP Good business practice, or GBP Good cell culture practice, or GCCP Good clinical data management practice, or GCDMP Good clinical laboratory practice, or GCLP Good clinical practice, or GCP Good documentation practice, or GDP, or GDocP (to distinguish from "good distribution practice") Good distribution practice, or GDP Good engineering practice, or GEP Good financial practice, or GFP Good guidance practice, or GGP Good hygiene practice, or GHP Good laboratory practice, or GLP Good machine learning practice, or GMLP Good management practice, or GMP Good manufacturing practice, or GMP Good microbiological practice, or GMiP Good participatory practice, or GPP Good pharmacovigilance practice, or GPvP or even GVP Good pharmacy practice, or GPP Good policing practice, or GPP Good recruitment practice, or GRP Good research practice, or GRP Good safety practice, or GSP Good storage practice, or GSP Good tissue practice, or GTP
Explosive trace detectors (ETD) are explosive detection equipment able to detect explosives of small magnitude. The detection is accomplished by sampling non-visible "trace" amounts of particulates. Devices similar to ETDs are also used to detect narcotics. The equipment is used mainly in airports and other vulnerable areas considered susceptible to acts of unlawful interference.
Main topics include mitigation of direct emissions of greenhouse gases in refrigeration, refrigerant charge reduction in refrigerating systems, magnetic cooling, life cycle climate performance evaluation, and refrigerant system safety.
Spinoff is a NASA publication featuring technology made available to the public. Since 1976, NASA has featured an average of 50 technologies each year in the annual publication, and Spinoff maintains a searchable database of these technologies. When products first spun off from space research, NASA presented a black and white report in 1973, titled the "Technology Utilization Program Report". Because of interest in the reports, NASA decided to create the annual publications in color. Spinoff was first published in 1976, and since then, NASA has distributed free copies to universities, the media, inventors and the general public. Spinoff describes how NASA works with various industries and small businesses to bring new technology to the public. As of 2016, there were over 1,920 Spinoff products in the database dating back to 1976.
Sources: en.wikipedia.org
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.
Typical endpoints include growth hormone pulse frequency and amplitude, together with insulin-like growth factor 1 concentration. Some protocols add body composition or metabolic markers. Interpretation depends on baseline hormonal status, which varies widely between individuals.
Most human data come from small, early-stage studies, and independent replication is limited. Short-term effects on growth hormone release are documented; longer-term outcomes are not well characterized. Open questions include changes in pituitary responsiveness after repeated exposure.
The synthetic peptide keeps the receptor-binding region of GHRH but carries substitutions that resist enzymatic cleavage. In the DAC version, an added group also anchors the molecule to albumin, extending its presence in the bloodstream.